EI
LRMR icon

Ethic Inc’s Larimar Therapeutics LRMR Stock Holding History

Ethic Inc’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.5K Sell
17,879
-17,572
-50% -$69.8K ﹤0.01% 1348
2026
Q1 		$160K Sell
35,451
-32,651
-48% -$131K ﹤0.01% 1169
2025
Q4 		$259K Sell
68,102
-7,295
-10% -$28.4K ﹤0.01% 1051
2025
Q3 		$244K Buy
75,397
+13,674
+22% +$51.3K ﹤0.01% 1044
2025
Q2 		$187K Buy
+61,723
New +$143K ﹤0.01% 1127

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Ethic Inc's LRMR Position: Q2 2026 in Review

Ethic Inc reduced its Larimar Therapeutics (LRMR) stake by 50% in Q2 2026, selling an estimated $69.8K and leaving 17,879 shares worth $54.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.

Ethic Inc first reported a position in LRMR in Q2 2025 and has held it in 5 quarters since. The position peaked at $259K in Q4 2025. 162 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Ethic Inc held 17,879 shares of Larimar Therapeutics worth $54.5K as of Q2 2026.
  • Ethic Inc sold 17,572 Larimar Therapeutics shares in Q2 2026, an estimated $69.8K.
  • Larimar Therapeutics made up ﹤0.01% of Ethic Inc's portfolio in Q2 2026, its #1348 holding.
  • Ethic Inc first reported a position in Larimar Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Ethic Inc's Larimar Therapeutics position peaked at $259K in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.